195 related articles for article (PubMed ID: 36306450)
1. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
2. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.
Yin H; Wang Z; Wang X; Lv X; Fan X; Yan M; Jia Y; Jiang L; Cao J; Liu Y
Biomed Chromatogr; 2021 Nov; 35(11):e5205. PubMed ID: 34192355
[TBL] [Abstract][Full Text] [Related]
5. Icaritin exhibits potential drug-drug interactions through the inhibition of human UDP-glucuronosyltransferase in vitro.
Rong Y; Li N; Qiao X; Yang L; Han P; Meng Z; Gan H; Wu Z; Zhu X; Sun Y; Liu S; Dou G; Gu R
Biopharm Drug Dispos; 2024 Jun; ():. PubMed ID: 38886878
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions.
Wang Z; Wang X; Wang Z; Jia Y; Feng Y; Jiang L; Xia Y; Cao J; Liu Y
Toxicol Lett; 2021 Sep; 348():10-17. PubMed ID: 34044055
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Chem Biol Interact; 2023 Aug; 381():110574. PubMed ID: 37263554
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
[TBL] [Abstract][Full Text] [Related]
9. Characterizations of Human UDP-Glucuronosyltransferase Enzymes in the Conjugation of p-Cresol.
Rong Y; Kiang TKL
Toxicol Sci; 2020 Aug; 176(2):285-296. PubMed ID: 32421801
[TBL] [Abstract][Full Text] [Related]
10. Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.
Dong DG; Zhang Y; Zhang SL; Lv J; Guo EM; Fang ZZ; Cao YF
Pharmazie; 2014 Jan; 69(1):60-3. PubMed ID: 24601226
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Liu Y; Ramírez J; House L; Ratain MJ
Drug Metab Dispos; 2010 Jan; 38(1):32-9. PubMed ID: 19850672
[TBL] [Abstract][Full Text] [Related]
12. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans.
Vrba J; Papoušková B; Lněničková K; Kosina P; Křen V; Ulrichová J
J Pharm Biomed Anal; 2020 Jan; 178():112972. PubMed ID: 31727359
[TBL] [Abstract][Full Text] [Related]
13. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.
Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L
Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958
[TBL] [Abstract][Full Text] [Related]
14. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
Luo CF; Cai B; Hou N; Yuan M; Liu SM; Ji H; Xiong LG; Xiong W; Luo JD; Chen MS
Arch Toxicol; 2012 Nov; 86(11):1681-90. PubMed ID: 22648071
[TBL] [Abstract][Full Text] [Related]
15. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3).
Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ
Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
Korprasertthaworn P; Chau N; Nair PC; Rowland A; Miners JO
Biochem Pharmacol; 2019 Nov; 169():113616. PubMed ID: 31445021
[TBL] [Abstract][Full Text] [Related]
18. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.
Kuehl GE; Bigler J; Potter JD; Lampe JW
Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
[TBL] [Abstract][Full Text] [Related]
20. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
